GL1X · GenesisL1 explorer

Ligand · NU6

NU6 · 3-[[6-(cyclohexylmethoxy)-9~{H}-purin-2-yl]amino]benzamide

NU6, 3-[[6-(cyclohexylmethoxy)-9~{H}-purin-2-yl]amino]benzamide (C19 H22 N6 O2, 366.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds…

Component
NU6
Formula
C19 H22 N6 O2
Class
ligand
Structures
2
PDB entries
1

Binding sites

NU6 in 2 structures; the first of them:

  • 5M51 · Nek2 bound to arylaminopurine compound 8 · NU6 A301 · binds ILE14, GLY15, THR16, GLY17, TYR19, VAL35, LYS37, VAL68 and 8 more
  • 5M51 · NEK2 bound to arylaminopurine compound 8 · NU6 A301 · binds ILE14, GLY15, THR16, GLY17, TYR19, VAL35, LYS37, VAL68 and 8 more

Residues it binds most

GLY 2, ASP 2, GLU 2, TYR 2, VAL 2, CYS 2, ILE 2, LYS 2, PHE 2, THR 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.